Online healthcare social networks (OHSNs) play an essential role in sharing information among medical experts and patients who are equipped with similar experiences. To access other patients’ data or experts’ diagnosis anywhere and anytime, it is necessary to integrate the OHSN into the Internet as part of the Internet of Things (IoT). Therefore, it is crucial to design an efficient and versatile access control scheme that can grant and revoke a user to access the OHSN. In this paper, we propose novel attribute-based encryption (ABE) features with user revocation and verifiable decryption outsourcing to control the access privilege of the users. The security of the proposed ABE scheme is given in the well-studied random oracle model. With the proposed ABE scheme, the malicious users can be excluded from the system and the user can offload most of the overhead in the decryption to an untrusted cloud server in a verifiable manner. An access control scheme for the OHSN has been given in the context of the IoT based on the proposed ABE scheme. The simulation demonstrates that our access control mechanism is practical.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rbvMiX
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jCvX3K via IFTTT
-
Treatment effectiveness holds considerable importance in the association between service quality and satisfaction in medical service studies...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2pbGdiN via IFTTT
-
Vol.25 No.2 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1P7bHxT via IFTTT
-
Publication date: Available online 16 January 2017 Source: International Journal of Pediatric Otorhinolaryngology Author(s): Kaveh Karimn...
-
Daily Mail Sarah was diagnosed with the cancer that killed Steve Jobs Daily Mail The symptoms Sarah Smith experienced on and off for...
-
Omalizumab is a treatment for asthma that has a success rate of approximately 40% to 50%.1 Recent mechanistic studies have suggested that ba...
-
Understanding Head And Neck Cancers - The Southeast Sun ... The Southeast Sun (NAPSI)—According to the Centers for Disease Control an...
-
Abstract Background Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involve...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου